Biomaterial can be injected intravenously and has potential application in heart attacks, traumatic brain injury

Glass laboratory flasks on light table

A new biomaterial, which can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair. The biomaterial was tested and proven effective in treating tissue damage caused by heart attacks in both rodent and large animal models. Researchers also provided proof of concept in a rodent model that the biomaterial could be beneficial to patients with traumatic brain injury and pulmonary arterial hypertension.

ICD detection and treatment of arrhythmias not impacted by MRI: Study

Previous article

Scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations